Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed Nov 13, 2024 · 10-Q · 44 days after period end · 0001520138-24-000425
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$4.15M | -$10.71M | -$10.42M | -$5.54M |
| EPS Diluted | -$0.70 | -$2.92 | -$0.38 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 13, 2024 · 44 d after period end
